SCHEMBL3978282

SCHEMBL3978282

C=C(C)C(=O)Oc1ccc(CCC)c(OCC)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.43
TSHR P16473 2/20 0.43
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
ALDH1A1 P00352 1/20 0.41
ELANE P08246 1/20 0.40
CYP3A4 P08684 1/20 0.39
MTNR1A P48039 1/20 0.38
MTNR1B P49286 1/20 0.38
ATM Q13315 1/20 0.38
STK17B O94768 1/20 0.36
GABRA1 P14867 1/20 0.36
GABRB2 P47870 1/20 0.36
PPARD Q03181 1/20 0.36
THRB P10828 1/20 0.35
ESR1 P03372 1/20 0.35
ESR2 Q92731 1/20 0.35
CREBBP Q92793 1/20 0.35
EPHX1 P07099 1/20 0.34
TDP1 Q9NUW8 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27324820 0.91 TSHR (0.42) KDM4ETSHRKMT2AMEN1ALDH1A1
SCHEMBL13385763 0.89 KDM4E (0.46) KDM4ETSHRKMT2AMEN1ALDH1A1
SCHEMBL8409499 0.86 TSHR (0.39) KDM4ETSHRKMT2AMEN1ALDH1A1
SCHEMBL14874608 0.85 ELANE (0.40) KDM4ETSHRKMT2AMEN1ALDH1A1
SCHEMBL10870368 0.84 KDM4E (0.49) KDM4ETSHRKMT2AMEN1ELANE
SCHEMBL27434188 0.84 KDM4E (0.49) KDM4ETSHRKMT2AALDH1A1ELANE
SCHEMBL28552774 0.84 KDM4E (0.42) KDM4ETSHRKMT2AMEN1ALDH1A1
SCHEMBL27969172 0.82 THRB (0.56) KDM4ETSHRKMT2AMEN1ALDH1A1
SCHEMBL15495926 0.82 ALDH1A1 (0.48) KDM4ETSHRKMT2AMEN1ALDH1A1
SCHEMBL27969027 0.82 KDM4E (0.47) KDM4ETSHRKMT2AMEN1ELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2056757-A2 BIOCOMPATIBLE STENT Den-Mat Holdings LLC (US) 2009-05-13 EP claimed
WO-2008027210-A2 BIOCOMPATIBLE STENT DEN-MAT HOLDINGS LLC (US) 2008-03-06 WO claimed
US-20080057096-A1 Comprising stent body, first layer applied over stent body comprising a therapeutic substance and second layer applied over first layer comprising a fluoride-containing hydrophilic water insoluble crosslinked resin; biocompatible layer leaches fluoride to provide further therapy to patient DEN-MAT CORPORATION 2008-03-06 US claimed
EP-0836636-A4 NOVEL DENTAL ADHESIVE DEN MAT CORP (US) 1998-10-14 EP claimed
EP-0836636-A1 NOVEL DENTAL ADHESIVE DEN-MAT CORPORATION (US) 1998-04-22 EP claimed
WO-1997040770-A1 NOVEL DENTAL ADHESIVE DEN-MAT CORPORATION (US) 1997-11-06 WO claimed
US-5683249-A Dental implant process and treated prosthetic DEN-MAT CORPORATION (US) 1997-11-04 US claimed
WO-1997002328-A1 NOVEL DENTAL ADHESIVE DEN-MAT CORPORATION (US) 1997-01-23 WO claimed
CN-104662012-B The preparation method of the keeping method of episulfide compound and the thio epoxiess optical material using above-mentioned episulfide compound 可奥熙搜路司有限公司 2017-04-05 CN disclosed
CN-104662012-A Method for storing episulfide compound and method for preparing thioepoxy-based optical material using said episulfide compound KOC SOLUTION CO LTD 2015-05-27 CN disclosed
CN-104640900-A Preparation method of thiourethane optical material KOC SOLUTION CO LTD 2015-05-20 CN disclosed
CN-104053657-A Process for producing thioepoxy optical material and polymerizable composition thereof KOC SOLUTION CO LTD 2014-09-17 CN disclosed
CN-104039860-A Polymerizable composition for thioepoxy-based optical material and method for producing thioepoxy-based optical material KOC SOLUTION CO LTD 2014-09-10 CN disclosed
CN-104024300-A POLYMERIZABLE COMPOSITION FOR OPTICAL MATERIAL CONTAINING THIOEPOXY COMPOUND, AND PREPARATION METHOD OF OPTICAL MATERIAL KOC SOLUTION CO LTD 2014-09-03 CN disclosed
EP-0715636-A1 ALLYL-EPOXY IPN AKZO NOBEL NV (NL) 1996-06-12 EP disclosed
WO-1996007683-A1 ALLYL-CONTAINING EPOXY RESIN COMPOSITION COMPRISING A COPOLYMER OF AN ETHYLENICALLY UNSATURATED ANHYDRIDE AND A VINYL COMPOUND AKZO NOBEL N.V. (NL) 1996-03-14 WO disclosed
WO-1995006075-A1 ALLYL-EPOXY IPN AKZO NOBEL N.V. (NL) 1995-03-02 WO disclosed
EP-0035574-B1 PHOTO-POLYMERIZABLE LIGHT-SENSITIVE RESIN COMPOSITION AND LIGHT-SENSITIVE SHEET MATERIAL ARAI, Tokuji (JP) 1985-02-06 EP disclosed
US-4370403-A BENZIL AND /DIMETHYLAMINO/BENZALDEHYDE PHOTOINITIATORS Arai, Tokuji (JP) 1983-01-25 US disclosed
EP-0035574-A1 PHOTO-POLYMERIZABLE LIGHT-SENSITIVE RESIN COMPOSITION AND LIGHT-SENSITIVE SHEET MATERIAL ARAI, Tokuji (JP) 1981-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080057096-A1 Comprising stent body, first layer applied over stent body comprising a therapeutic substance and second layer applied over first layer comprising a fluoride-containing hydrophilic water insoluble crosslinked resin; biocompatible layer leaches fluoride to provide further therapy to patient FGB, CSTB, FGFR2 KDM4E 4380/4885TSHR 1654/4885KMT2A 2473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.